Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PF-03882845

Generic Name: PF-03882845

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₂₂ClN_₃O_₂

CAS Number: 1023650-66-9

Unique Ingredient Identifier: 34ZKU73FU3

Overview

PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.

Background

PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Phase 1

Terminated

Posted: 2011/12/08

Sponsor:Pfizer

ID:NCT01488877

A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

Phase 1

Completed

Posted: 2011/06/06

Sponsor:Pfizer

ID:NCT01366287

A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers

Phase 1

Completed

Posted: 2011/03/15

Sponsor:Pfizer

ID:NCT01314898

A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers

Phase 1

Completed

Posted: 2009/09/04

Sponsor:Pfizer

ID:NCT00971802

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy